ARCHIVES

Immunotherapy Shrinks Tumors In Phase I Study at St. Jude

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Terry To Leave As DRCCA Acting Director Sept. 1, Peter Greenwald Is DeVita’s Choice For The Job

August 14, 1981

ACS Awards Grants Totaling $31.3 Million

January 25, 1985

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

March 28, 2014

Tykerb Plus Letrozole Delayed Metastatic Breast Cancer

January 30, 2009

ODAC Chairman: Time Was Tight For Meeting

November 10, 1995

Paraplatin Lengthened TTP In HER2+ Advanced Breast Ca

January 31, 2003